In general, while our results did quantitatively align with previously reported differences between MSI and MSS CRC (e.g. quantities of IFNG+ or CXC13+CD8+ T cells1, subtle exhaustion phenotypes18), these were too subtle to account for the very big clinico-immunological differences between these subtypes. The gene discussed is IFNG; the disease is colorectal carcinoma.